Clinton Health Access Initiative- Request For Quotation For The Study “The Impact Of Pre-Emptive Home Delivery Of Ors + Zinc On Treatment For Child Diarrhea In Bauchi, Nigeria – The At Home Trial”


CLINTON HEALTH ACCESS INITIATIVE

REQUEST FOR QUOTATION (RFQ)

FOR THE STUDY “THE IMPACT OF PRE-EMPTIVE HOME DELIVERY OF ORS + ZINC ON TREATMENT FOR CHILD DIARRHEA IN BAUCHI, NIGERIA – THE AT HOME TRIAL”

BID REF: RFP/CHAING/ORSZINC/01  

SPECIFICATIONS AND INSTRUCTIONS TO BIDDERS

The Clinton Health Access Initiative (CHAI) is a global health organization committed to strengthening integrated health systems and expanding access to care and treatment for HIV/AIDS, Malaria tuberculosis, cancer, and other diseases. For more information, please visit http://www.clintonhealthaccess.org.

The RAND Corporation is a research organization that develops objective solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier, and more prosperous. RAND is non-profit, non partism, and committed to the public interest.

Diarrhea is the second leading cause of death for children in low-and middle-income countries (LMICs) Nigeria accounts for almost 13% of these deaths globally with approximately – 100,000 Nigerian children dying each year due to diarrheal illness. Oral rehydration salts (ORS) and zinc is recommended by the World Health Organization (WHO) to effectively treat and prevent diarrhea. One promising approach for increasing ORS use is delivering the product directly to the home for free prior to a child having a case of diarrhea.

CHAI is designing and implementing a program in Bauchi, Nigeria, to distribute free ORS and zinc co-packs to all households with children under age 5. Alongside the program, CHAI will be working with RAND to conduct a randomized controlled trial (RCT) to estimate the effect of free and convenient provision of ORS and zinc on subsequent usage of ORS and zinc by children under 5 years with diarrhea.

CHAI and the RAND Corporation invite interested and capable research agencies to submit proposals for the study, “the Impact of pre-emptive home delivery of ORS + zinc on treatment for children diarrhea in Bauchi, Nigeria – the At home trial”.

Interested organizations can send their proposals electronically with this reference in the subject “Submission for bid Ref: RFP/CHAING/ORSZINC/01” to [email protected] by 29th February, 2024, 11:59pm WAT addressed in the following manner:

The Country Director

Clinton Health Access Initiative

#7 Ganges Street Off Alvan Ikoku Way, Maitama,

Abuja, Nigeria.

Attention: CHAI Nigeria Procurement (BID REF: RFP/CHAING/ORSZINC/01).

All bids must be received by 29th February, 2024 by 11:59pm (WAT). Late/incomplete proposals will not be accepted in any circumstances. Proposals received after the due date and to any other email address will not be considered.

Detailed description of the Request for Proposal can be accessed via this link https://clintonhealth.box.com/s/p9c366mh57a7gr6pwldbnd605qnak3ko

DISCLAIMER:

Distribution of the document does not mean there is any comment on the part of CHAI to award a contract or fund an applicant. CHAI will not reimburse or otherwise bear any cost associated with this RFP regardless of whether an organization is selected to undertake the supply. Please note that no fee is required in submission of these applications. CHAI makes on representation or warranty and shall incur no liability whatsoever under any law as to the accuracy, reliability or completeness of the information contained in the RFP.